Cargando…

Synaptic Plasticity, Metaplasticity and Depression

The development of a persistent depressive affective state has for some time been thought to result from persistent alterations in neurotransmitter-mediated synaptic transmission. While the identity of those transmitters has changed over the years, the literature has lacked mechanistic connections b...

Descripción completa

Detalles Bibliográficos
Autores principales: Vose, Linnea R., Stanton, Patric K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327460/
https://www.ncbi.nlm.nih.gov/pubmed/26830964
http://dx.doi.org/10.2174/1570159X14666160202121111
_version_ 1782510735048310784
author Vose, Linnea R.
Stanton, Patric K.
author_facet Vose, Linnea R.
Stanton, Patric K.
author_sort Vose, Linnea R.
collection PubMed
description The development of a persistent depressive affective state has for some time been thought to result from persistent alterations in neurotransmitter-mediated synaptic transmission. While the identity of those transmitters has changed over the years, the literature has lacked mechanistic connections between the neurophysiological mechanisms they regulate, and how these mechanisms alter neuronal function, and, hence, affective homeostasis. This review will examine recent work that suggests that both long-term activity-dependent changes in synaptic strength (“plasticity”), and shifting set points for the ease of induction of future long-term changes (“metaplasticity”), may be critical to establishing and reversing a depressive behavioral state. Activity-dependent long-term synaptic plasticity involves both strengthening and weakening of synaptic connections associated with a dizzying array of neurochemical alterations that include synaptic insertion and removal of a number of subtypes of AMPA, NMDA and metabotropic glutamate receptors, changes in presynaptic glutamate release, and structural changes in dendritic spines. Cellular mechanisms of metaplasticity are far less well understood. Here, we will review the growing evidence that long-term synaptic changes in glutamatergic transmission, in brain regions that regulate mood, are key determinants of affective homeostasis and therapeutic targets with immense potential for drug development.
format Online
Article
Text
id pubmed-5327460
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-53274602017-07-01 Synaptic Plasticity, Metaplasticity and Depression Vose, Linnea R. Stanton, Patric K. Curr Neuropharmacol Article The development of a persistent depressive affective state has for some time been thought to result from persistent alterations in neurotransmitter-mediated synaptic transmission. While the identity of those transmitters has changed over the years, the literature has lacked mechanistic connections between the neurophysiological mechanisms they regulate, and how these mechanisms alter neuronal function, and, hence, affective homeostasis. This review will examine recent work that suggests that both long-term activity-dependent changes in synaptic strength (“plasticity”), and shifting set points for the ease of induction of future long-term changes (“metaplasticity”), may be critical to establishing and reversing a depressive behavioral state. Activity-dependent long-term synaptic plasticity involves both strengthening and weakening of synaptic connections associated with a dizzying array of neurochemical alterations that include synaptic insertion and removal of a number of subtypes of AMPA, NMDA and metabotropic glutamate receptors, changes in presynaptic glutamate release, and structural changes in dendritic spines. Cellular mechanisms of metaplasticity are far less well understood. Here, we will review the growing evidence that long-term synaptic changes in glutamatergic transmission, in brain regions that regulate mood, are key determinants of affective homeostasis and therapeutic targets with immense potential for drug development. Bentham Science Publishers 2017-01 2017-01 /pmc/articles/PMC5327460/ /pubmed/26830964 http://dx.doi.org/10.2174/1570159X14666160202121111 Text en © 2017 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Vose, Linnea R.
Stanton, Patric K.
Synaptic Plasticity, Metaplasticity and Depression
title Synaptic Plasticity, Metaplasticity and Depression
title_full Synaptic Plasticity, Metaplasticity and Depression
title_fullStr Synaptic Plasticity, Metaplasticity and Depression
title_full_unstemmed Synaptic Plasticity, Metaplasticity and Depression
title_short Synaptic Plasticity, Metaplasticity and Depression
title_sort synaptic plasticity, metaplasticity and depression
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327460/
https://www.ncbi.nlm.nih.gov/pubmed/26830964
http://dx.doi.org/10.2174/1570159X14666160202121111
work_keys_str_mv AT voselinnear synapticplasticitymetaplasticityanddepression
AT stantonpatrick synapticplasticitymetaplasticityanddepression